Leiomyoma of the uterus is the most common tumor of the female pelvis, arising from the uterine smooth muscle. Its prevalence increases during the reproductive age and is seen in nearly half of the women over the age of 35 [1]. Large myomas with degenerations located towards the adnexa may mimic an ovarian neoplasm and can impose a challenge in its diagnosis. Radiological modalities like ultras...

BACKGROUND In the ovary, sarcomatoid carcinoma has been reported only as mural nodules in epithelial malignant or borderline serous or mucinous cystic neoplasms, and in teratomas. In this paper we report a rare case of a solid sarcomatoid carcinoma of the ovary, without accompanying component of giant cells, pleomorphic cells, or glandular and other epithelial structures. CASE PRESENTATION Th...

A patient with postmenopausal bleeding and virilization was found to have bilaterally enlarged ovaries with a yellow cut surface. Histology revealed cortical stromal hyperplasia with stromal hyperthecosis. This hyperplastic condition should not be mistaken for an ovarian neoplasm.

Background: Ovarian neoplasms are the second most common cause of gynecological malignancy both worldwide as well in India. Innocuous clinical presentation and late diagnosis contribute to mortality toll this neoplasm. Thus, early remains cornerstone increase survival rate ovarian neoplasms. Though, cancer antigen 125 (CA-125) is a time-tested marker for neoplasm yet its increment benign condit...

While ovarian masses are common findings in gynecology, unusually huge masses are quite rare. However, such cases can still be found today. Mismanagement of common complaints in patients can be a leading cause of facing such findings. Herein, we introduce a case of a giant ovarian cyst, which was mismanaged in a young virgin female patient. The patient had received gastrointestinal medications ...

Ovarian neoplasms are group of aggressive and lethal diseases. Surgical and radiochemical therapies on ovarian neoplasm are conventional approaches but with limited progress in years. Targeted therapy with drugs targeting specific genetic alterations and/or protein molecules have brought new hope fighting against ovarian neoplasms. Targeted therapy on genetic alterations of BRAF, ROS-1 and HER2...